NOT-HL-20-800: Notice of Expiration of NOT-HL-20-782 "Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials"

Notice of Expiration of NOT-HL-20-782 "Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials"

Notice Number:

NOT-HL-20-800

Key Dates

Release Date:

July 24, 2020

Related Announcements

PA-20-135 - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

NOT-HL-20-782 - Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform the extramural research community that NOT-HL-20-782 "Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials" will expire on July 31, 2020. Applications will continue to be accepted for NOT-HL-20-782 through July 31, 2020 by 5:00 PM local time of the applicant organization. An application submitted in response to NOT-HL-20-782 that is received on August 01, 2020 or later will be withdrawn.

Inquiries

Please direct all inquiries to:

Patricia Noel, PhD
National Heart, Lung, and Blood Institute
Division of Lung Diseases
Telephone: 301-435-0202
Email: [email protected]

Nahed El Kassar, MD, PhD
National Heart, Lung, and Blood Institute
Division of Blood Diseases and Resources
Telephone: 301-827-8268
Email: [email protected]

Emily Tinsley PhD, MS
National Heart, Lung, and Blood Institute
Division of Cardiovascular Sciences
Telephone: 301-435-0519
Email: [email protected]